IHAM
Integral Health Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-50,000
| Closed | -$4.33M | – | 67 |
|
|
2023
Q2 | $4.33M | Sell |
50,000
-50,000
| -50% | -$4.33M | 0.54% | 58 |
|
|
2023
Q1 | $9.72M | Sell |
100,000
-70,000
| -41% | -$6.81M | 1.96% | 20 |
|
|
2022
Q4 | $17.6M | Buy |
170,000
+63,000
| +59% | +$6.52M | 3.69% | 3 |
|
|
2022
Q3 | $9.07M | Sell |
107,000
-19,286
| -15% | -$1.63M | 1.76% | 21 |
|
|
2022
Q2 | $10.5M | Buy |
126,286
+46,286
| +58% | +$3.84M | 2.15% | 15 |
|
|
2022
Q1 | $6.17M | Buy |
80,000
+32,000
| +67% | +$2.47M | 1.61% | 24 |
|
|
2021
Q4 | $4.24M | Buy |
48,000
+30,000
| +167% | +$2.65M | 1.17% | 32 |
|
|
2021
Q3 | $1.39M | Sell |
18,000
-7,000
| -28% | -$541K | 0.4% | 62 |
|
|
2021
Q2 | $2.09M | Sell |
25,000
-27,000
| -52% | -$2.25M | 0.57% | 51 |
|
|
2021
Q1 | $3.93M | Sell |
52,000
-33,000
| -39% | -$2.49M | 1.12% | 36 |
|
|
2020
Q4 | $7.45M | Sell |
85,000
-35,000
| -29% | -$3.07M | 2.22% | 20 |
|
|
2020
Q3 | $9.13M | Buy |
120,000
+40,000
| +50% | +$3.04M | 2.79% | 12 |
|
|
2020
Q2 | $9.87M | Sell |
80,000
-30,000
| -27% | -$3.7M | 2.95% | 5 |
|
|
2020
Q1 | $9.3M | Hold |
110,000
| – | – | 4.09% | 6 |
|
|
2019
Q4 | $9.3M | Buy |
+110,000
| New | +$9.3M | 3.62% | 7 |
|